SGMO Financial Facts
Basic and diluted net loss per share: -0.13Research grants: 540K
See Full Income Statement
Commitments and contingencies: 0
Total current assets: 61.55M
See Full Balance Sheet
Earnings History for Sangamo Biosciences Inc. (SGMO)
|
Expand Research on SGMO
| Next EPS Date | 7/24/13 *Est. | EPS Growth Rate | +7.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +25.8% | Revenue Growth Rate | +44.4% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/13  |
 |
Q113 | -$0.13 | -$0.16 | +$0.03 | $4.62M | $3.79M | N/A / N/A | = | -0.4% | Details |
| 2/6/13 |
|
Q412 | -$0.07 | -$0.12 | +$0.05 | $8.9M | $5.95M | N/A / N/A | = | -16.6% | Details |
| 10/24/12 |
|
Q312 | -$0.11 | -$0.14 | +$0.03 | $4.9M | $3.8M | N/A / N/A | = | +38% | Details |
| 7/25/12 |
|
Q212 | -$0.11 | -$0.14 | +$0.03 | $4.6M | $3.65M | N/A / N/A | = | +58.4% | Details |
| 5/2/12 | Q112 | -$0.14 | -$0.16 | +$0.02 | $3.2M | $3.38M | N/A / N/A | = | +75.8% | Details | |
| 2/8/12 |
|
Q411 | -$0.12 | -$0.12 | $0.00 | $4.7M | $3.41M | N/A / N/A | = | +64% | Details |
| 10/25/11 |
|
Q311 | -$0.18 | -$0.16 | -$0.02 | $1.9M | $2.82M | N/A / N/A | = | 0% | Details |
| 7/27/11 |
|
Q211 | -$0.20 | -$0.16 | -$0.04 | $1.5M | $2.65M | N/A / N/A | = | +39.8% | Details |
